共查询到20条相似文献,搜索用时 0 毫秒
1.
犬瘟热病毒H蛋白基因重组腺病毒的构建及免疫效果评估 总被引:1,自引:0,他引:1
研究选取犬瘟热病毒H蛋白基因为目的基因,利用反转录聚合酶链式反应(RT-PCR)、酶切、连接等方法构建出重组人5型腺病毒穿梭质粒和骨架质粒,两者共转染293AD细胞并包装出重组腺病毒。通过电镜负染、酶切鉴定、Western blot及一步生长曲线测定等方法进行病毒的生物学特性鉴定,证明犬瘟热病毒H蛋白基因重组腺病毒构建正确。犬分别肌肉接种CDV疫苗毒和重组腺病毒,并检测免疫后第14,28,42,56,70,84d时犬血清中抗CDV中和抗体的变化情况。结果显示,犬免疫重组腺病毒后体内产生的抗CDV平均中和抗体水平高于对照组,滴度最高达2-8。研究表明,正确构建的重组腺病毒具有良好的免疫原性,诱导产生的抗犬瘟热病毒中和抗体达到犬最低免疫保护水平,为进一步研发犬瘟热病毒活载体疫苗提供理论依据。 相似文献
2.
核蛋白基因(N)位于犬瘟热病毒基因组的108—1679位置处,是保守性较强的免疫原性蛋白,因此选择N基因作为目的基因,利用酶切、连接等方法构建了含犬瘟热病毒核蛋白基因的穿梭质粒pVAX?E3LPN。以含CAV-2SY株全基因组的pPoly2-CAV-2为载体,构建了重组质粒pCAV-2-CDVLPN,利用脂质体介导法转染MDCK细胞,转染三次后,细胞出现了典型的腺病毒样病变。电镜负染、切片观察,酶切、PCR扩增及测序鉴定的结果表明表达犬瘟热核蛋白基因的重组犬2型腺病毒构建成功,表达的核蛋白分子量为58kDa。 相似文献
3.
犬瘟热病毒核蛋白基因重组腺病毒的构建、鉴定与表达 总被引:2,自引:0,他引:2
核蛋白基因(N)位于犬瘟热病毒基因组的108-1679位置处,是保守性较强的免疫原性蛋白,因此选择N基因作为目的基因,利用酶切、连接等方法构建了含犬瘟热病毒核蛋白基因的穿梭质粒pVAXAE3LPN.以含CAV-2 SY株全基因组的pPoly2-CAV-2为载体,构建了重组质粒pCAV-2-CDVLPN,利用脂质体介导法转染MDCK细胞,转染三次后,细胞出现了典型的腺病毒样病变.电镜负染、切片观察,酶切、PCR.扩增及测序鉴定的结果表明表达犬瘟热核蛋白基因的重组犬2型腺病毒构建成功,表达的核蛋白分子量为58kDa. 相似文献
4.
Misako Yoneda Marie-Claude Georges-Courbot Fusako Ikeda Miho Ishii Noriyo Nagata Frederic Jacquot Hervé Raoul Hiroki Sato Chieko Kai 《PloS one》2013,8(3)
Nipah virus (NiV) is a member of the genus Henipavirus, which emerged in Malaysia in 1998. In pigs, infection resulted in a predominantly non-lethal respiratory disease; however, infection in humans resulted in over 100 deaths. Nipah virus has continued to re-emerge in Bangladesh and India, and person-to-person transmission appeared in the outbreak. Although a number of NiV vaccine studies have been reported, there are currently no vaccines or treatments licensed for human use. In this study, we have developed a recombinant measles virus (rMV) vaccine expressing NiV envelope glycoproteins (rMV-HL-G and rMV-Ed-G). Vaccinated hamsters were completely protected against NiV challenge, while the mortality of unvaccinated control hamsters was 90%. We trialed our vaccine in a non-human primate model, African green monkeys. Upon intraperitoneal infection with NiV, monkeys showed several clinical signs of disease including severe depression, reduced ability to move and decreased food ingestion and died at 7 days post infection (dpi). Intranasal and oral inoculation induced similar clinical illness in monkeys, evident around 9 dpi, and resulted in a moribund stage around 14 dpi. Two monkeys immunized subcutaneously with rMV-Ed-G showed no clinical illness prior to euthanasia after challenge with NiV. Viral RNA was not detected in any organ samples collected from vaccinated monkeys, and no pathological changes were found upon histopathological examination. From our findings, we propose that rMV-NiV-G is an appropriate NiV vaccine candidate for use in humans. 相似文献
5.
Nathalie Sixt Alicia Cardoso Agnès Vallier Jo?l Fayolle Robin Buckland T. Fabian Wild 《Journal of virology》1998,72(11):8472-8476
We have studied the immune responses to the two glycoproteins of the Morbillivirus canine distemper virus (CDV) after DNA vaccination of BALB/c mice. The plasmids coding for both CDV hemagglutinin (H) and fusion protein (F) induce high levels of antibodies which persist for more than 6 months. Intramuscular inoculation of the CDV DNA induces a predominantly immunoglobulin G2a (IgG2a) response (Th1 response), whereas gene gun immunization with CDV H evokes exclusively an IgG1 response (Th2 response). In contrast, the CDV F gene elicited a mixed, IgG1 and IgG2a response. Mice vaccinated (by gene gun) with either the CDV H or F DNA showed a class I-restricted cytotoxic lymphocyte response. Immunized mice challenged intracerebrally with a lethal dose of a neurovirulent strain of CDV were protected. However, approximately 30% of the mice vaccinated with the CDV F DNA became obese in the first 2 months following the challenge. This was not correlated with the serum antibody levels.Inoculation of plasmid DNA into muscle and the subsequent expression of the encoded protein have opened up new approaches in vaccination and gene therapy (for an extensive review see reference 25). Although initial studies used intramuscular (i.m.) inoculation to deliver the DNA, other routes have been shown to be equally or more efficient in inducing immune responses, which may be related to the types of antigen-presenting cells (APCs) which are involved (9). Recent observations suggest that after i.m. inoculation, muscle cells probably act as a reservoir for the foreign antigen, while the bone marrow cells seem to act as the APCs (8, 12, 26, 27). For DNA delivery to the skin, the APCs have not yet been identified but could well include cells of dendritic origin (21). Although both intradermal and i.m. DNA inoculations induce a strong Th1 response, inoculation of DNA precipitated onto gold beads and delivered by means of a gene gun favors a Th2 response (7). Whether this is due to the targeting of different APCs has not been determined.We have been studying the possibility of using DNA vaccination to protect against canine distemper virus (CDV). CDV is a member of the genus Morbillivirus, in the Paramyxoviridae family, and although this virus primarily infects dogs, the disease has also been described in several animal species both in nature and in captivity (10, 18, 22). The currently available live attenuated vaccine efficiently protects dogs once maternal antibodies have disappeared, but it is not sufficiently attenuated for certain other animal species in which a fatal infection may ensue (6). This has led to a problem in protecting members of rare animal species living in captivity.In the present study, we have expressed the two CDV glycoproteins, the attachment protein (hemagglutinin [H]) and the fusion protein (F), from plasmids driven by a cytomegalovirus (CMV) promoter. We show that i.m. and intradermal inoculation of the CDV H-encoding plasmid induces a Th1 response, whereas gene gun inoculation of the same plasmid induces a Th2-type response. In contrast, the CDV F gene administered with the gene gun elicited a mixed Th response. Mice immunized with either of the plasmids were protected against a lethal intracerebral (i.c.) infection. 相似文献
6.
本试验以犬2型腺病毒全基因组重组质粒pPolyⅡCAV 2及其E3 区重组质粒pVAX E3 为基础,通过DraⅢ和SspⅠ双酶切,缺失第25097bp 26141bp共1044bp的E3区片段,按与编码链相同转录方向插入由CMV启动子、狂犬病病毒SRV9 株糖蛋白基因、SV40 polyA基因构成的总长2424bp的表达盒,获得重组基因组质粒pPolyⅡCAV 2 CGS(34.7kb)。以AscⅠ和ClaⅠ双酶切,游离重组基因组(32.7kb),在脂质体LipofectamineTM 2000 介导下,转染MDCK细胞系,获得了E3 缺失区携带狂犬病病毒糖蛋白表达盒的重组犬2 型腺病毒CAV 2 CGS。Western印迹试验表明,CAV 2 CGS表达了狂犬病病毒糖蛋白。初步接种试验显示,重组病毒可以诱导犬产生狂犬病病毒特异性抗体。 相似文献
7.
Jonathan H. Epstein Michelle L. Baker Carlos Zambrana-Torrelio Deborah Middleton Jennifer A. Barr Edward DuBovi Victoria Boyd Brian Pope Shawn Todd Gary Crameri Allyson Walsh Katey Pelican Mark D. Fielder Angela J. Davies Lin-Fa Wang Peter Daszak 《PloS one》2013,8(6)
Old World frugivorous bats have been identified as natural hosts for emerging zoonotic viruses of significant public health concern, including henipaviruses (Nipah and Hendra virus), Ebola virus, and Marburg virus. Epidemiological studies of these viruses in bats often utilize serology to describe viral dynamics, with particular attention paid to juveniles, whose birth increases the overall susceptibility of the population to a viral outbreak once maternal immunity wanes. However, little is understood about bat immunology, including the duration of maternal antibodies in neonates. Understanding duration of maternally derived immunity is critical for characterizing viral dynamics in bat populations, which may help assess the risk of spillover to humans. We conducted two separate studies of pregnant Pteropus bat species and their offspring to measure the half-life and duration of antibodies to 1) canine distemper virus antigen in vaccinated captive Pteropus hypomelanus; and 2) Hendra virus in wild-caught, naturally infected Pteropus alecto. Both of these pteropid bat species are known reservoirs for henipaviruses. We found that in both species, antibodies were transferred from dam to pup. In P. hypomelanus pups, titers against CDV waned over a mean period of 228.6 days (95% CI: 185.4–271.8) and had a mean terminal phase half-life of 96.0 days (CI 95%: 30.7–299.7). In P. alecto pups, antibodies waned over 255.13 days (95% CI: 221.0–289.3) and had a mean terminal phase half-life of 52.24 days (CI 95%: 33.76–80.83). Each species showed a duration of transferred maternal immunity of between 7.5 and 8.5 months, which was longer than has been previously estimated. These data will allow for more accurate interpretation of age-related Henipavirus serological data collected from wild pteropid bats. 相似文献
8.
表达狂犬病病毒糖蛋白的重组犬2型腺病毒的构建 总被引:3,自引:0,他引:3
本试验以犬2型腺病毒全基因组重组质粒pPolyⅡ-CAV-2及其E3区重组质粒pVAX-E3为基础,通过DraⅢ和SspⅠ双酶切,缺失第25097bp-26141bp共1044bp的E3区片段,按与编码链相同转录方向插入由CMV启动子、狂犬病病毒SRV\-9株糖蛋白基因、SV40 polyA基因构成的总长2424bp的表达盒,获得重组基因组质粒pPolyⅡ-CAV-2-CGS(34.7kb).以AscⅠ和ClaⅠ双酶切,游离重组基因组(32.7kb),在脂质体Lipofectamine TM 2000介导下,转染MDCK细胞系,获得了E3缺失区携带狂犬病病毒糖蛋白表达盒的重组犬2型腺病毒CAV-2-CGS.Western印迹试验表明,CAV-2-CGS表达了狂犬病病毒糖蛋白.初步接种试验显示,重组病毒可以诱导犬产生狂犬病病毒特异性抗体. 相似文献
9.
Continuous-Flow Ultracentrifugation of Canine Distemper Virus and Infectious Canine Hepatitis Virus 总被引:1,自引:1,他引:0
下载免费PDF全文
![点击此处可从《Applied microbiology》网站下载免费的PDF全文](/ch/ext_images/free.gif)
The use of a Spinco L-4 zonal centrifuge with the B-XVI continuous-flow rotor for the purification of canine distemper and infectious canine hepatitis viruses is described. Up to 68 liters of virus was processed at one time. Infectious canine hepatitis virus was found to band at 39% sucrose and canine distemper virus banded between 32 and 48% sucrose. The virus was concentrated 10-fold, and the purity of the virus, as measured by protein concentration, was increased by 99%. 相似文献
10.
Farnaz Zahedifard Elham Gholami Tahereh Taheri Yasaman Taslimi Fatemeh Doustdari Negar Seyed Fatemeh Torkashvand Claudio Meneses Barbara Papadopoulou Shaden Kamhawi Jesus G. Valenzuela Sima Rafati 《PLoS neglected tropical diseases》2014,8(3)
Background
Novel vaccination approaches are needed to prevent leishmaniasis. Live attenuated vaccines are the gold standard for protection against intracellular pathogens such as Leishmania and there have been new developments in this field. The nonpathogenic to humans lizard protozoan parasite, Leishmania (L) tarentolae, has been used effectively as a vaccine platform against visceral leishmaniasis in experimental animal models. Correspondingly, pre-exposure to sand fly saliva or immunization with a salivary protein has been shown to protect mice against cutaneous leishmaniasis.Methodology/Principal Findings
Here, we tested the efficacy of a novel combination of established protective parasite antigens expressed by L. tarentolae together with a sand fly salivary antigen as a vaccine strategy against L. major infection. The immunogenicity and protective efficacy of different DNA/Live and Live/Live prime-boost vaccination modalities with live recombinant L. tarentolae stably expressing cysteine proteinases (type I and II, CPA/CPB) and PpSP15, an immunogenic salivary protein from Phlebotomus papatasi, a natural vector of L. major, were tested both in susceptible BALB/c and resistant C57BL/6 mice. Both humoral and cellular immune responses were assessed before challenge and at 3 and 10 weeks after Leishmania infection. In both strains of mice, the strongest protective effect was observed when priming with PpSP15 DNA and boosting with PpSP15 DNA and live recombinant L. tarentolae stably expressing cysteine proteinase genes.Conclusion/Significance
The present study is the first to use a combination of recombinant L. tarentolae with a sand fly salivary antigen (PpSP15) and represents a novel promising vaccination approach against leishmaniasis. 相似文献11.
Petra van den Doel Asisa Volz Jouke M. Roose Varsha D. Sewbalaksing Gorben P. Pijlman Ingeborg van Middelkoop Vincent Duiverman Eva van de Wetering Gerd Sutter Albert D. M. E. Osterhaus Byron E. E. Martina 《PLoS neglected tropical diseases》2014,8(9)
Chikungunya virus (CHIKV) infection is characterized by rash, acute high fever, chills, headache, nausea, photophobia, vomiting, and severe polyarthralgia. There is evidence that arthralgia can persist for years and result in long-term discomfort. Neurologic disease with fatal outcome has been documented, although at low incidences. The CHIKV RNA genome encodes five structural proteins (C, E1, E2, E3 and 6K). The E1 spike protein drives the fusion process within the cytoplasm, while the E2 protein is believed to interact with cellular receptors and therefore most probably constitutes the target of neutralizing antibodies. We have constructed recombinant Modified Vaccinia Ankara (MVA) expressing E3E2, 6KE1, or the entire CHIKV envelope polyprotein cassette E3E26KE1. MVA is an appropriate platform because of its demonstrated clinical safety and its suitability for expression of various heterologous proteins. After completing the immunization scheme, animals were challenged with CHIV-S27. Immunization of AG129 mice with MVAs expressing E2 or E3E26KE1 elicited neutralizing antibodies in all animals and provided 100% protection against lethal disease. In contrast, 75% of the animals immunized with 6KE1 were protected against lethal infection. In conclusion, MVA expressing the glycoprotein E2 of CHIKV represents as an immunogenic and effective candidate vaccine against CHIKV infections. 相似文献
12.
通过介绍犬瘟热流行病学特点,结合犬瘟热病毒在灵长类动物的感染情况,对犬瘟热的危害及公共卫生意义进行了分析。指出犬瘟热病毒存在大范围流行风险从而对进出口猴场形成新的威胁,并根据工作实际提出了疫病疫情预防控制和检验检疫监督管理的着重点。 相似文献
13.
为构建能表达FPV VP2蛋白的重组犬2型腺病毒(CAV-2)载体。首先用PCR方法从FPV GT-2株细胞培 养物中扩增出了VP2蛋白基因,将其克隆到真核表达质粒pVAX1中构建了含有FPV vp2基因的表达盒(CMV- VP2-PolyA),将该表达盒酶切后定向克隆到含有CAV-2 E3区的穿梭质粒pVAX△E3中,构建出pVAX △E3VP2。用Sal I Nru I双酶切pVAX△E3VP2,回收含有目的基因表达盒部分,将其定向克隆入含有CAV-2 全基因组的骨架质粒pPoly2-CAV-2中,构建了重组质粒pCAV-2-FPV-VP2。Cla I Asc I酶切pCAV-2-FPV- VP2释放出重组基因组,以此转染MDCK细胞,获得了重组病毒CAV-2-VP2。该重组病毒能使MDCK细胞产生 腺病毒样细胞病变。Western blot检测证实,该重组病毒能表达具有免疫学活性的VP2蛋白。该重组病毒可以有 效地诱导免疫猫产生抗FPV和CAV-2抗体。本实验表明该重组病毒有可能成为一个FPV的疫苗株。 相似文献
14.
为构建能表达FPV VP2蛋白的重组犬2型腺病毒(CAV-2)载体.首先用PCR方法从FPV GT-2株细胞培养物中扩增出了VP2蛋白基因,将其克隆到真核表达质粒pVAX1中构建了含有FPV vp2基因的表达盒(CMV-VP2-PolyA),将该表达盒酶切后定向克隆到含有CAV-2 E3区的穿梭质粒pVAX△E3中,构建出pVAX△E3VP2.用Sal I+Nru I双酶切pVAX△E3VP2,回收含有目的基因表达盒部分,将其定向克隆入含有CAV-2全基因组的骨架质粒pPoly2-CAV-2中,构建了重组质粒pCAV-2-FPV-VP2.Cla I+Asc I酶切pCAV-2-FPV-VP2释放出重组基因组,以此转染MDCK细胞,获得了重组病毒CAV-2-VP2.该重组病毒能使MDCK细胞产生腺病毒样细胞病变.Western blot检测证实,该重组病毒能表达具有免疫学活性的VP2蛋白.该重组病毒可以有效地诱导免疫猫产生抗FPV和CAV-2抗体.本实验表明该重组病毒有可能成为一个FPV的疫苗株. 相似文献
15.
犬瘟热病毒细胞膜受体的鉴定 总被引:16,自引:0,他引:16
犬瘟热病毒(CDV)敏感细胞Vero用SDS或RIPA溶解缓冲液溶解,利用病毒铺覆蛋白印迹技术(VOPBA)鉴定犬瘟热病毒疫苗株(CDV-ondestepoort)的细胞受体。结果发现,在Vero细胞上有两组CDV结合蛋白质,即高分子量组蛋白质(127kD、120kD、110kD)与低分子量组蛋白质(27kD和30kD)。这些CDV结合蛋白组分的性质及在CDV致病中的作用有等进一步研究。 相似文献
16.
Recombinant Canine Coronaviruses Related to Transmissible Gastroenteritis Virus of Swine Are Circulating in Dogs
下载免费PDF全文
![点击此处可从《Journal of virology》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Nicola Decaro Viviana Mari Marco Campolo Alessio Lorusso Michele Camero Gabriella Elia Vito Martella Paolo Cordioli Luis Enjuanes Canio Buonavoglia 《Journal of virology》2009,83(3):1532-1537
Four canine coronavirus type II (CCoV-II) strains were identified in the guts and internal organs of pups which had died of acute gastroenteritis. The CCoV-II strains were strictly related to porcine transmissible gastroenteritis virus (TGEV) in the N-terminal domain of the spike protein, whereas in the other parts of the genome, a higher genetic relatedness to recent CCoV-II isolates was observed. Experimental infection of dogs with a TGEV-like isolate induced mild gastroenteritis without any systemic involvement. By virus neutralization tests, antigenic differences between reference and TGEV-like CCoVs were found. Our data support the potential recombinant origin of the TGEV-like CCoVs. 相似文献
17.
Recombinant Measles AIK-C Vaccine Strain Expressing the prM-E Antigen of Japanese Encephalitis Virus
An inactivated Japanese encephalitis virus (JEV) vaccine, which induces neutralizing antibodies, has been used for many years in Japan. In the present study, the JEV prM-E protein gene was cloned, inserted at the P/M junction of measles AIK-C cDNA, and an infectious virus was recovered. The JEV E protein was expressed in B95a cells infected with the recombinant virus. Cotton rats were inoculated with recombinant virus. Measles PA antibodies were detected three weeks after immunization. Neutralizing antibodies against JEV developed one week after inoculation, and EIA antibodies were detected three weeks after immunization. The measles AIK-C-based recombinant virus simultaneously induced measles and JEV immune responses, and may be a candidate for infant vaccines. Therefore, the present strategy of recombinant viruses based on a measles vaccine vector would be applicable to the platform for vaccine development. 相似文献
18.
目的建立水貂犬瘟热动物模型,并利用水貂犬瘟热模型评价不同犬瘟热强毒株的毒力,为水貂犬瘟热病毒疫苗的研究奠定基础。方法从猴、藏獒、犬的病料中分离犬瘟热病毒,测定犬瘟热病毒的毒力,并进行传代培养。利用犬的犬瘟热动物模型筛选稳定的犬瘟热强毒株,进行水貂犬瘟热动物模型的建立及其毒力评估。结果筛选出了稳定的犬瘟热强毒株并进行了家犬动物实验,同时表现出了强烈的临床症状,并利用不同的代次毒进行了犬瘟热动物模型的建立。结论成功建立了犬瘟热动物模型并对不同来源的犬瘟热病毒毒力进行了评估。 相似文献
19.
表达EB病毒主要膜蛋白gp350/220的非复制型重组痘苗病毒的构建 总被引:1,自引:0,他引:1
利用非复制痘苗病毒质粒载体pNEOCK11β75及pNEOCK,改造了表达EB病毒主要膜蛋白gp350/22的复制型重组痘苗病毒VMA,构建了非复制型重组痘苗病毒VMA△CK。该病毒能在鸡胚原代成纤维细胞(CEF)中正常繁殖,而在人源细胞中不能正常繁殖。在CEF中连续传代至第25代,经PCR证明,该病毒符合非复制型重组痘苗病毒的特征。经免疫荧光及免疫酶斑法证实,VMA△CK可稳定表达gp350/220,且表达水平与VAM无明显差异。VMA△CK经腹腔免疫Balb/C小鼠,4周后能诱生一定水平的抗gp350/220特异性抗体,加强免疫2周后该抗体水平明显升高。这一结果类似于VMA免疫Balb/C小鼠的结果,初免后,VMA△CK且抗痘苗抗体水平明显低于VMA免疫组;加强免疫2周后,两组小鼠的抗痘苗抗体水平趋于一致。上述结果证明,所构建的非复制痘苗病毒不影响目的抗原的表达,也不影响该抗原的免疫原性,但导致病毒毒力下降,而且用该病毒免疫小鼠后小鼠抗痘苗病毒载体的免疫反应明显下降。 相似文献